Company: AGIO
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001193125-25-096719
Chunk: 78

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 78
---
 Code. In general, all of our employees are eligible to participate, beginning on the first day of the month following commencement of their employment. The 401(k) plan includes a salary deferral arrangement pursuant to which participants may elect to reduce their current compensation by up to the statutorily prescribed limit, equal to $23,000 in 2024, and have the amount of the reduction contributed to the 401(k) plan. Participants who turned age 50 in 2024 were also eligible to make “catch-up”contributions, which in 2024 may be up to an additional $7,500 above the statutory limit. In 2024, we matched 100% of employee 401(k) contributions up to the first 4% of eligible contributions. Matching contributions are 100% vested immediately. Policies and Practices Related to the Grant of Certain Equity Awards On an annual basis, we grant stock options and RSUs to our employees and also grant PSUs to certain employees including our executive officers. We grant options and RSUs to our non-employeedirectors on an annual basis in accordance with our non-employeedirector compensation policy.We also grant stock options, RSUs and, with respect to our executive officers and certain others, PSUs, to individuals upon hire or, in limited circumstances, promotion or for retention purposes. We currently do not grant stock appreciation rights or similar option-like instruments. During the year ended December 31, 2024, neither the board of directors nor the compensation committee took material nonpublic information into account when determining the timingor terms of equity awards, nor did the Company timethe disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. Annual stock option grants to our executive officers are typically granted by our compensation committee (or in the case of the chief executive officer, by our board of directors) effective on March 1 stof each year. Stock options granted to new hires who are executive officers are typically granted by our board of directors effective upon such executive officer’s employment start date. In 2024, our compensation committee delegated authority to our chief executive officer, or if the chief executive officer was unavailable, the chief financial officer, under our 2023 Stock Incentive Plan to grant annual stock grants to our non-executiveofficer employees effective on March 1 stof the year. Stock options granted to new hires who are non-executiveemployees are typically granted pursuant to delegated authority by our chief executive officer, or if the chief executive